Breast Cancer Now Annual Report 2017/18
At Breast Cancer Now we believe that, by 2050, everyone who develops breast cancer lives – and lives well. We proudly present our Annual Report and Accounts 2017/18 that shows the progress we have made to take us ever closer to our 2050 ambition.
Our accounts from previous years
* This report represents an amalgamation of results from Breast Cancer Campaign and Breakthrough Breast Cancer up to 31 March 2015, plus the results of the merged charity, Breast Cancer Now, from 1 April to 31 July 2015.
Pharmaceutical donations 2013 - 2018
The Breast Cancer Now Catalyst Programme
The Breast Cancer Now Catalyst Programme, is an initiative which aims to bring together Europe’s leading breast cancer researchers and the world’s leading pharmaceutical companies to pool resources and stop women dying from breast cancer by 2050. The first collaborator signed up to the Catalyst Programme is the biopharmaceutical company Pfizer. Pfizer has committed $15m USD (around £10m) over three years, which opens an exciting opportunity for breast cancer research.
The programme aims to enable Europe’s leading researchers to design independently selected research programmes, using companies’ existing breast cancer drugs or molecules that they’re still working on in their laboratories. We aim to speed up the translation of research into new more effective targeted treatments and therapies for breast cancer patients.
Please contact our Supporter Engagement team with any questions by emailing email@example.com or calling 0333 20 70 300.